Stifel Financial
BDTX icon

Stifel Financial’s Black Diamond Therapeutics BDTX Stock Holding History

Stifel Financial’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520K Buy
281,245
+2,600
+0.9% +$6.36K ﹤0.01% 2947
2026
Q1 		$594K Buy
278,645
+3,650
+1% +$8.68K ﹤0.01% 2763
2025
Q4 		$668K Buy
274,995
+52,750
+24% +$187K ﹤0.01% 2696
2025
Q3 		$842K Buy
222,245
+2,300
+1% +$6.73K ﹤0.01% 2500
2025
Q2 		$545K Buy
219,945
+13,045
+6% +$25.1K ﹤0.01% 2723
2025
Q1 		$321K Buy
206,900
+40,900
+25% +$85.8K ﹤0.01% 2930
2024
Q4 		$355K Buy
166,000
+15,676
+10% +$44.9K ﹤0.01% 2883
2024
Q3 		$654K Buy
150,324
+2,824
+2% +$15.4K ﹤0.01% 2504
2024
Q2 		$687K Sell
147,500
-800
-0.5% -$4.29K ﹤0.01% 2416
2024
Q1 		$752K Buy
148,300
+36,600
+33% +$148K ﹤0.01% 2375
2023
Q4 		$314K Buy
111,700
+91,600
+456% +$215K ﹤0.01% 2817
2023
Q3 		$57.7K Buy
+20,100
New +$74K ﹤0.01% 3172

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Stifel Financial's BDTX Position: Q2 2026 in Review

Stifel Financial increased its Black Diamond Therapeutics (BDTX) stake by 0.93% in Q2 2026, buying an estimated $6.36K and bringing the position to 281,245 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

Stifel Financial first reported a position in BDTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $842K in Q3 2025. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Stifel Financial held 281,245 shares of Black Diamond Therapeutics worth $520K as of Q2 2026.
  • Stifel Financial bought 2,600 Black Diamond Therapeutics shares in Q2 2026, an estimated $6.36K.
  • Black Diamond Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2947 holding.
  • Stifel Financial first reported a position in Black Diamond Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Stifel Financial's Black Diamond Therapeutics position peaked at $842K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.